<DOC>
	<DOCNO>NCT01689337</DOCNO>
	<brief_summary>This Phase 2 , double-blind , multicenter , randomize , placebo-controlled trial evaluate efficacy safety Sprifermin ( AS902330 ) ( recombinant human fibroblast growth factor-18 [ rhFGF-18 ] ) adjunct treatment subject follow microfracture ( MFx ) surgery cartilage injury knee . Primary Objectives - To evaluate effect Sprifermin ( AS902330 ) intra-articular knee injection adjunct microfracture ( MFx ) surgery composition refill cartilage target knee , measure gadolinium-enhanced magnetic resonance imaging ( MRI ) cartilage ( dGEMRIC ) time constant 1 ( T1 ) relaxation time 6 month MFx surgery - To evaluate safety profile Sprifermin ( AS902330 ) administer intra-articular knee adjunct MFx surgery subject cartilage injury knee Secondary Objectives - To support efficacy safety Sprifermin ( AS902330 ) adjunct MFx cartilage injury repair symptomatic outcome quantitative MRI measurement</brief_summary>
	<brief_title>A Multicenter Trial Sprifermin ( AS902330 Recombinant Human Fibroblast Growth Factor-18 ) Placebo After Microfracture Surgery Cartilage Injury Knee</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Knee Injuries</mesh_term>
	<criteria>Subjects candidature MFx surgery femoral articular surface ( medial lateral condyle trochlear groove ) , intact subchondral bone Subjects moderate severe pain target knee prior surgery ; average score great equal ( &gt; = ) 4.0 7 consecutive day numeric rating scale pain intensity ( complete within 30 [ +15 ] day surgery ) Intraoperative inclusion criterion : Subjects 1 2 focal chondral lesion per target knee , peripheral debridement healthy cartilage result follow : Each lesion area &gt; = 1 square centimeter ( cm^2 ) less equal ( &lt; = ) 4 cm^2 Each lesion &lt; = 6 millimeter ( mm ) depth , measure surround subchondral plate Arthroscopic confirmation nonosteochondritis dissecans ( OCD ) lesion International Cartilage Repair Society ( ICRS ) Grades I III ( D ) ; Grade III nonOCD lesion equivalent Outerbridge Grade IV lesion minimal subchondral bone loss Other protocoldefined inclusion criterion could apply Subjects prior marrow stimulation treatment target knee , , MFx , microdrilling , abrasion chondroplasty cartilage repair include , limited , autologous chondrocyte implantation ( ACI ) , matrix/membrane autologous chondrocyte implantation ( MACI ) , osteochondral transplantation ( autologous allogeneic ) Subjects body mass index ( BMI ) great 35 kilogram per square meter ( kg/m^2 ) screen Malalignment target knee great 5 degree measure mechanical axis , confirm alignment ( long bone ) Xray image Subjects clinical and/or radiographic disease diagnosis target knee joint include , limited following : generalize osteoarthritis ( OA ) , rheumatoid arthritis , avascular necrosis Subjects contraindication MRI gadoliniumbased iodinate contrast agent accord site 's standard practice guideline Other protocoldefined exclusion criterion could apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Microfracture surgery</keyword>
	<keyword>Cartilage repair</keyword>
	<keyword>Knee surgery</keyword>
</DOC>